SCHEMBL6708672

SCHEMBL6708672

O=C(COc1ccccc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CETP P11597 1/20 0.41
POLB P06746 1/20 0.40
G6PD P11413 1/20 0.40
ALDH1A1 P00352 2/20 0.40
THRB P10828 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PRSS12 P56730 1/20 0.40
GRIK1 P39086 1/20 0.40
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
SERPINE1 P05121 1/20 0.39
MAPT P10636 1/20 0.39
GAA P10253 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709883 0.94 GAA (0.47) NPC1RAB9AL3MBTL1POLBG6PD
SCHEMBL6714076 0.91 KMT2A (0.41) NPC1RAB9AL3MBTL1POLBALDH1A1
SCHEMBL6713838 0.90 GRIK1 (0.41) POLBALDH1A1GRIK1MAPTTP53
SCHEMBL6707994 0.89 CETP (0.43) CETPPOLBG6PDGRIK1SERPINE1
SCHEMBL6710078 0.89 ALDH1A1 (0.37) NPC1RAB9AL3MBTL1POLBALDH1A1
SCHEMBL6710410 0.88 USP2 (0.43) POLBGRIK1MAPTTP53LMNA
SCHEMBL6709861 0.88 GRIK1 (0.41) L3MBTL1POLBALDH1A1GRIK1TP53
SCHEMBL6710141 0.88 GRIK1 (0.44) PRSS12GRIK1SERPINE1RXFP1
SCHEMBL6709877 0.87 GRIK1 (0.43) NPC1RAB9APOLBALDH1A1GRIK1
SCHEMBL6712543 0.87 GRIK1 (0.43) POLBGRIK1MAPTRXFP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 NPC1 3891/4885RAB9A 3732/4885L3MBTL1 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.